In my current role as Head of Bioelectronics at Merck Healthcare KGaA, I am leading a strategic growth field, from research to market, to transform cutting edge technology into viable business for Merck.
From January 2015 until May 2017, I managed the biotech ANTEIS S.A. in Geneva as the General Manager/CEO with the full profit & loss responsibility. Prior to this, I was employed by Merz Pharmaceuticals in various management positions including Head Global R&D Medical Devices. Most importantly at Merz, I achieved launch readiness for the biologic XEOMIN addressing a Euro 500 million market opportunity in the USA.
My mission is to spearhead healthcare businesses, committed to their people and for the best of values, organizational excellence and innovation.

Our passion for science and technology is what drives our around 63,000 employees in 65 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live. We are here for people at every step, helping to create, improve and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community. Our tools, services and digital platform make research simpler, more exact, and help deliver breakthroughs more quickly. Our solutions accelerate access to health by assuring tests are accurate and the medicine we take can be trusted. We are the company behind the companies, advancing digital living. Our science sits inside technologies that are changing the way we access, store, process, and display information. Our innovations are unlocking the power and potential of data to open new possibilities to transform life on Earth as we know it. Thanks to the constant curiosity of our employees, we are making discoveries that can change the landscape of entire industries. For more than 350 years, we have been pushing the boundaries of what is possible, and we will continue to do so in the years to come.